Exclusive: Two Vida Ventures co-founders exit the VC firm

Max Bayer

Pharma Reporter

Kyle LaHucik

Senior Reporter

Arjun Goyal and Stefan Vitorovic, two of Vida Ventures’ three co-founding managing directors, have exited the firm as it rejigs its leadership team seven years …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Two Vida Ventures co-founders exit the VC firm

Max Bayer

Pharma Reporter

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Judge halts some NIH cuts after 22 states sue

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Eli Lilly inks $630M deal for Phase 1 MASH candidate

Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

Boehringer Ingelheim touts success in second Phase 3 lung fibrosis trial

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

Ex­clu­sive: Two Vi­da Ven­tures co-founders ex­it the VC firm

Pharma Reporter

Senior Reporter

Sign up to read this article for free.

Exclusive: Two Vida Ventures co-founders exit the VC firm